The Chinese AI company doesn’t want to bother with funding—at least not right now. WSJ reporter Rebecca Feng discusses why <a href="https://www.wsj.com/tech/ai/investors-want-a-piece-of-deepseek-its-founder-says-not-now-24e9f799?mod=WSJ_TNBPOD">DeepSeek</a> is so hesitant. Plus, how will federal funding cuts impact drug development? WSJ enterprise technology bureau chief Steven Rosenbush explains the impact on the <a href="https://www.wsj.com/articles/bioscience-funding-confusion-threatens-u-s-innovation-ab0efc30?mod=WSJ_TNBPOD">bioscience</a> industry. Shara Tibken hosts.

Sign up for the WSJ's free <a href="https://www.wsj.com/newsletters/technology?mod=WSJ_TNBPOD">Technology newsletter</a>.
 Learn more about your ad choices. Visit <a href="https://megaphone.fm/adchoices">megaphone.fm/adchoices</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

DeekSeek Resists Bringing on Investors

WSJ Tech News Briefing

AI Chapters

AI Insights

Reviews